Cargando…

New Oxidovanadium(IV) Coordination Complex Containing 2-Methylnitrilotriacetate Ligands Induces Cell Cycle Arrest and Autophagy in Human Pancreatic Ductal Adenocarcinoma Cell Lines

Pancreatic cancer is characterized by one of the lowest five-year survival rates. In search for new treatments, some studies explored several metal complexes as potential anticancer drugs. Therefore, we investigated three newly synthesized oxidovanadium(IV) complexes with 2-methylnitrilotriacetate (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowalski, Szymon, Wyrzykowski, Dariusz, Hac, Stanislaw, Rychlowski, Michal, Radomski, Marek Witold, Inkielewicz-Stepniak, Iwona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358955/ https://www.ncbi.nlm.nih.gov/pubmed/30634697 http://dx.doi.org/10.3390/ijms20020261

Ejemplares similares

Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosis, apoptosis and mitotic catastrophe process
por: Kowalski, Szymon, et al.
Publicado: (2017)

Molecular and Cellular Mechanisms of Cytotoxic Activity of Vanadium Compounds against Cancer Cells
por: Kowalski, Szymon, et al.
Publicado: (2020)

Synthesis, Spectroscopic Characterization, Catalytic and Biological Activity of Oxidovanadium(V) Complexes with Chiral Tetradentate Schiff Bases
por: Romanowski, Grzegorz, et al.
Publicado: (2023)

Molecular Mechanism of Silver Nanoparticles-Induced Human Osteoblast Cell Death: Protective Effect of Inducible Nitric Oxide Synthase Inhibitor
por: Zielinska, Ewelina, et al.
Publicado: (2016)

Titanium dioxide nanoparticles enhance production of superoxide anion and alter the antioxidant system in human osteoblast cells
por: Niska, Karolina, et al.
Publicado: (2015)

Therapeutic Potential of Multifunctional Tacrine Analogues
por: Przybyłowska, Maja, et al.
Publicado: (2019)

Characterization and cytotoxic effect of aqua-(2,2′,2′′-nitrilotriacetato)-oxo-vanadium salts on human osteosarcoma cells
por: Tesmar, Aleksandra, et al.
Publicado: (2017)

Silver nanoparticles of different sizes induce a mixed type of programmed cell death in human pancreatic ductal adenocarcinoma
por: Zielinska, Ewelina, et al.
Publicado: (2017)

Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors
por: Przybyłowska, Maja, et al.
Publicado: (2021)

Design, synthesis and biological evaluation of novel N-phosphorylated and O-phosphorylated tacrine derivatives as potential drugs against Alzheimer’s disease
por: Przybyłowska, Maja, et al.
Publicado: (2022)

Pharmacological and toxicological effects of co-exposure of human gingival fibroblasts to silver nanoparticles and sodium fluoride
por: Inkielewicz-Stepniak, Iwona, et al.
Publicado: (2014)

Di-μ-chlorido-bis[diacetonitrilechloridooxidovanadium(IV)]
por: Dastych, Dalibor, et al.
Publicado: (2011)

cis-Dichloridobis(ethyl methyl sulfide-κS)oxidovanadium(IV)
por: Matsuura, Masatoshi, et al.
Publicado: (2013)

Role of Oxidative and Nitro-Oxidative Damage in Silver Nanoparticles Cytotoxic Effect against Human Pancreatic Ductal Adenocarcinoma Cells
por: Barcińska, Ewelina, et al.
Publicado: (2018)

Effects of functionalized silver nanoparticles on aggregation of human blood platelets
por: Hajtuch, Justyna, et al.
Publicado: (2019)

The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells
por: Hajtuch, Justyna, et al.
Publicado: (2022)

Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target
por: Mai, Shaoshan, et al.
Publicado: (2021)

Ligand substitution reactions of a phenolic quinolyl hydrazone; oxidovanadium (IV) complexes
por: Seleem, Hussein S, et al.
Publicado: (2011)

Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme
por: Ferraro, Giarita, et al.
Publicado: (2022)

Shape-Depended Biological Properties of Ag(3)PO(4) Microparticles: Evaluation of Antimicrobial Properties and Cytotoxicity in In Vitro Model—Safety Assessment of Potential Clinical Usage
por: Steckiewicz, Karol P., et al.
Publicado: (2019)

Modified Nanoparticles as Potential Agents in Bone Diseases: Cancer and Implant-Related Complications
por: Steckiewicz, Karol P., et al.
Publicado: (2020)

Exploring Oxidovanadium(IV) Complexes as YopH Inhibitors: Mechanism of Action and Modeling Studies
por: Martins, Priscila G. A., et al.
Publicado: (2015)

Structurally Characterized BODIPY-Appended Oxidovanadium(IV) β-Diketonates for Mitochondria-Targeted Photocytotoxicity
por: Bhattacharyya, Utso, et al.
Publicado: (2020)

ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins
por: Ugone, Valeria, et al.
Publicado: (2020)

Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach
por: Cappai, Rosita, et al.
Publicado: (2021)

The Role of Mucin in the Toxicological Impact of Polystyrene Nanoparticles
por: Inkielewicz-Stepniak, Iwona, et al.
Publicado: (2018)

(2,2′-Bipyridine)(pyridine-2,6-dicarboxylato)oxidovanadium(IV) ethanol monosolvate
por: Aghabozorg, Hossein, et al.
Publicado: (2011)

On the Capability of Oxidovanadium(IV) Derivatives to Act as All-Around Catalytic Promoters Since the Prebiotic World
por: Campitelli, Patrizio, et al.
Publicado: (2020)

Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP
por: Sciortino, Giuseppe, et al.
Publicado: (2020)

The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation
por: Santos-Martinez, Maria Jose, et al.
Publicado: (2012)

A Novel Oxidovanadium (IV)-Orotate Complex as an Alternative Antidiabetic Agent: Synthesis, Characterization, and Biological Assessments
por: Naglah, Ahmed M., et al.
Publicado: (2018)

QSAR Modeling, Molecular Docking and Cytotoxic Evaluation for Novel Oxidovanadium(IV) Complexes as Colon Anticancer Agents
por: Alomari, Fatimah Y., et al.
Publicado: (2022)

A Multi-Technique Investigation of the Complex Formation Equilibria between Bis-Deferiprone Derivatives and Oxidovanadium (IV)
por: Cappai, Rosita, et al.
Publicado: (2022)

Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency
por: Iwicka, Eliza, et al.
Publicado: (2022)

trans-Bis(1,3-diphenylpropane-1,3-dionato)(methanol)oxidovanadium(IV) methanol disolvate
por: Pretorius, Carla, et al.
Publicado: (2012)

Synthesis, Characterization, and In Vitro Insulin-Mimetic Activity Evaluation of Valine Schiff Base Coordination Compounds of Oxidovanadium(V)
por: Turtoi, Mihaela, et al.
Publicado: (2021)

Theoretical Investigation by DFT and Molecular Docking of Synthesized Oxidovanadium(IV)-Based Imidazole Drug Complexes as Promising Anticancer Agents
por: Basaleh, Amal S., et al.
Publicado: (2022)

Bis(4,4′-dimethyl-2,2′-bipyridine)oxidovanadium(IV) Sulfate Dehydrate: Potential Candidate for Controlling Lipid Metabolism?
por: Francik, Renata, et al.
Publicado: (2017)

Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An In Vitro Study. Concerns about Potential Application in Dental Practice
por: Niska, Karolina, et al.
Publicado: (2016)

{2,2′-[Ethylenebis(nitrilomethylidyne)]diphenolato-κ(4) O,N,N′,O′}oxidovanadium(IV)
por: Wang, Cheng, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ovpp7g6mgn5djuihbilfgu5n8j